Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.56 | 27.24 |
| PEG Ratio (TTM) | 0.02 | 42.91 |
| P/S Ratio (TTM) | 1.60 | 7.39 |
| P/B Ratio (TTM) | 1.02 | 6.17 |
| P/FCF Ratio (TTM) | -7.38 | 22.98 |
| Price to 5YR AVG Earnings Ratio | 10.95 | 70.65 |
| Price to 5YR AVG FCF Ratio | -53.65 | 36.74 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.73% | 6.18% |
| ROE (TTM) | -17.66% | 20.00% |
| Net Profit Margin (TTM) | -28.80% | 6.57% |
| ROIC 5YR AVG | 8.70% | 11.92% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2,121.60% | -40.31% | 277.18% |
| Revenue | -10.11% | -0.04% | 30.25% |
| Net Income | -2,114.90% | -39.91% | 281.82% |
| Cash Flow | 80.22% | -4.71% | 81.90% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.44 | 1.57 |
| Quick Ratio (TTM) | 1.58 | 1.13 |
| D/E Ratio (TTM) | 0.35 | 0.94 |
| Interest Coverage (TTM) | -15.05 | 13.91 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.61 | 3.60 |
| LTL to 5YR AVG FCF | -18.82 | 6.70 |
| Shares Outstanding Growth 5YR AVG | 1.66% | 3.57% |